Peter Rohoň

460 total citations
33 papers, 283 citations indexed

About

Peter Rohoň is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Peter Rohoň has authored 33 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 16 papers in Genetics and 8 papers in Rheumatology. Recurrent topics in Peter Rohoň's work include Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (16 papers) and Acute Myeloid Leukemia Research (10 papers). Peter Rohoň is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (16 papers) and Acute Myeloid Leukemia Research (10 papers). Peter Rohoň collaborates with scholars based in Czechia, Finland and Slovakia. Peter Rohoň's co-authors include Satu Mustjoki, Kimmo Porkka, Karel Indrák, Edgar Faber, Jukka Vakkila, Anna Kreutzman, Marie Jarošová, Tomáš Szotkowski, Teresa Pinho e Melo and Vesa Juvonen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Peter Rohoň

31 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Rohoň Czechia 9 208 155 71 67 66 33 283
Yasuji Kouzai Japan 10 269 1.3× 155 1.0× 90 1.3× 63 0.9× 84 1.3× 20 322
F. Iuliano Italy 6 256 1.2× 204 1.3× 145 2.0× 68 1.0× 86 1.3× 9 328
Anna Lübking Sweden 9 156 0.8× 109 0.7× 66 0.9× 65 1.0× 55 0.8× 14 236
Shady Adnan Awad Finland 11 174 0.8× 124 0.8× 46 0.6× 60 0.9× 65 1.0× 23 299
Mridul Agrawal United States 8 187 0.9× 128 0.8× 30 0.4× 46 0.7× 33 0.5× 12 289
Raimondo Ferrara Italy 6 206 1.0× 83 0.5× 33 0.5× 80 1.2× 124 1.9× 8 291
Mary Alikian United Kingdom 11 204 1.0× 177 1.1× 55 0.8× 22 0.3× 80 1.2× 18 346
Maho Ishikawa Japan 10 143 0.7× 88 0.6× 36 0.5× 40 0.6× 53 0.8× 40 277
G. Penfold South Africa 7 290 1.4× 251 1.6× 63 0.9× 53 0.8× 50 0.8× 12 412
Heather Cazzolli United States 5 270 1.3× 204 1.3× 33 0.5× 41 0.6× 26 0.4× 8 369

Countries citing papers authored by Peter Rohoň

Since Specialization
Citations

This map shows the geographic impact of Peter Rohoň's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rohoň with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rohoň more than expected).

Fields of papers citing papers by Peter Rohoň

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Rohoň. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rohoň. The network helps show where Peter Rohoň may publish in the future.

Co-authorship network of co-authors of Peter Rohoň

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Rohoň. A scholar is included among the top collaborators of Peter Rohoň based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Rohoň. Peter Rohoň is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Švec, Peter, et al.. (2023). The Importance of New EBMT Criteria on the Diagnosis of Veno-Occlusive Liver Disease in Children. Journal of Clinical Medicine. 12(3). 826–826. 4 indexed citations
2.
Rohoň, Peter, et al.. (2020). Short stature and SHOX (Short stature homeobox) variants—efficacy of screening using various strategies. PeerJ. 8. e10236–e10236. 5 indexed citations
3.
Steinerová, Kateřina, Michal Karas, Peter Rohoň, et al.. (2019). First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. Leukemia Research. 81. 67–74. 6 indexed citations
4.
Raida, Luděk, Tomáš Szotkowski, Peter Rohoň, et al.. (2018). Granulocyte transfusions collected after steroid priming for severe infections during neutropenia: A single center experience. Transfusion Clinique et Biologique. 26(4). 299–303.
5.
6.
7.
Jonášová, Anna, Jaroslav Čermák, Monika Beličková, et al.. (2015). [Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience].. PubMed. 61(12). 1028–33. 1 indexed citations
8.
Raida, Luděk, et al.. (2014). Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasms. International Journal of Hematology. 100(6). 582–591. 4 indexed citations
9.
Ilander, Mette, Anna Kreutzman, Peter Rohoň, et al.. (2014). Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy. PLoS ONE. 9(1). e87794–e87794. 27 indexed citations
10.
Szotkowski, Tomáš, et al.. (2013). Spontaneous splenic rupture in a patient with acute promyelocytic leukaemia during induction chemotherapy. Biomedical Papers. 159(2). 294–298. 3 indexed citations
11.
Faber, Edgar, et al.. (2012). Interferon-alpha in chronic myeloid leukemia revisited: A long-term retrospective study in Central and Northern Moravia. Biomedical Papers. 157(3). 248–256. 1 indexed citations
12.
Rohoň, Peter. (2012). Biological therapy and the immune system in patients with chronic myeloid leukemia. International Journal of Hematology. 96(1). 1–9. 14 indexed citations
13.
Faber, Edgar, et al.. (2011). Operational Cures After Interferon-Alpha in Patients with Chronic Myeloid Leukemia in Central and Northern Moravia. Journal of Interferon & Cytokine Research. 32(5). 230–234. 1 indexed citations
14.
Rohoň, Peter, Luděk Raida, Edgar Faber, et al.. (2011). IDENTIFICATION OF E6A2 BCR-ABL FUSION IN A PHILADELPHIA-POSITIVE CML WITH MARKED BASOPHILIA: IMPLICATIONS FOR TREATMENT STRATEGY. Biomedical Papers. 155(2). 187–190. 6 indexed citations
15.
16.
Kreutzman, Anna, Peter Rohoň, Edgar Faber, et al.. (2011). Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile. PLoS ONE. 6(8). e23022–e23022. 35 indexed citations
17.
18.
Szotkowski, Tomáš, et al.. (2010). Secondary acute myeloid leukemia – a single center experience. Neoplasma. 57(2). 170–178. 20 indexed citations
19.
Rohoň, Peter, Kimmo Porkka, & Satu Mustjoki. (2010). Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy. European Journal Of Haematology. 85(5). 387–398. 71 indexed citations
20.
Rohoň, Peter, et al.. (2008). SUCCESSFUL CHILDBIRTH IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH IMATINIB MESYLATE DURING EARLY PREGNANCY. Biomedical Papers. 152(1). 121–123. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuji Kouzai Breakdown of academic impact, for papers by F. Iuliano Breakdown of academic impact, for papers by Anna Lübking Breakdown of academic impact, for papers by Shady Adnan Awad Breakdown of academic impact, for papers by Mridul Agrawal Breakdown of academic impact, for papers by Raimondo Ferrara Breakdown of academic impact, for papers by Mary Alikian Breakdown of academic impact, for papers by Maho Ishikawa Breakdown of academic impact, for papers by G. Penfold Breakdown of academic impact, for papers by Heather Cazzolli
Rankless by CCL
2026